INGN Strangle Strategy
INGN (Inogen, Inc.), in the Healthcare sector, (Medical - Devices industry), listed on NASDAQ.
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
INGN (Inogen, Inc.) trades in the Healthcare sector, specifically Medical - Devices, with a market capitalization of approximately $184.4M, a beta of 1.65 versus the broader market, a 52-week range of 5.34-9.13, average daily share volume of 322K, a public-listing history dating back to 2014, approximately 766 full-time employees. These structural characteristics shape how INGN stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.65 indicates INGN has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a strangle on INGN?
A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.
Current INGN snapshot
As of May 15, 2026, spot at $6.39, ATM IV 60.70%, IV rank 21.73%, expected move 17.40%. The strangle on INGN below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this strangle structure on INGN specifically: INGN IV at 60.70% is on the cheap side of its 1-year range, which favors premium-buying structures like a INGN strangle, with a market-implied 1-standard-deviation move of approximately 17.40% (roughly $1.11 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated INGN expiries trade a higher absolute premium for lower per-day decay. Position sizing on INGN should anchor to the underlying notional of $6.39 per share and to the trader's directional view on INGN stock.
INGN strangle setup
The INGN strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With INGN near $6.39, the first option leg uses a $6.71 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed INGN chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 INGN shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $6.71 | N/A |
| Buy 1 | Put | $6.07 | N/A |
INGN strangle risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.
INGN strangle payoff curve
Modeled P&L at expiration across a range of underlying prices for the strangle on INGN. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use strangle on INGN
Strangles on INGN are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the INGN chain.
INGN thesis for this strangle
The market-implied 1-standard-deviation range for INGN extends from approximately $5.28 on the downside to $7.50 on the upside. A INGN long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current INGN IV rank near 21.73% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on INGN at 60.70%. As a Healthcare name, INGN options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to INGN-specific events.
INGN strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. INGN positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move INGN alongside the broader basket even when INGN-specific fundamentals are unchanged. Always rebuild the position from current INGN chain quotes before placing a trade.
Frequently asked questions
- What is a strangle on INGN?
- A strangle on INGN is the strangle strategy applied to INGN (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With INGN stock trading near $6.39, the strikes shown on this page are snapped to the nearest listed INGN chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are INGN strangle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the INGN strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 60.70%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a INGN strangle?
- The breakeven for the INGN strangle priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current INGN market-implied 1-standard-deviation expected move is approximately 17.40%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a strangle on INGN?
- Strangles on INGN are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the INGN chain.
- How does current INGN implied volatility affect this strangle?
- INGN ATM IV is at 60.70% with IV rank near 21.73%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.